◀ Back to EPHB2

CCNE1 — EPHB2

Text-mined interactions from Literome

Ko et al., Exp Cell Res 2004 (Adenocarcinoma...) : Decreasing phospho-ERK with the pharmacological inhibitors, PD98059 and U0126, markedly suppresses hyperoxia stimulated phospho-p53 ( Ser15 ), p53, and p21 ( CIP1 ), and also restores the hyperoxia reduced kinase activities of cyclin D1/E1-Cdks
Ugland et al., Mol Biol Cell 2008 : Concomitant with this growth inhibition, however, cyclin E levels are increased in a MEK/ERK dependent manner